Fig. 3From: Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factorsOverall survival for the subgroup of patients with high squamous cell carcinoma level. Significant difference was found in overall survival between patients who did and did not receive concurrent chemotherapy (P = 0.015)Back to article page